SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following the surprise announcement of a $1 billion convertible senior notes offering, fueling intense community debate over management's credibility and the timing of the capital raise. While some investors view the financing as a strategic move to accelerate satellite deployment and secure launch capabilities, others are aggressively rotating out of the stock, citing broken promises regarding previous dilution and mounting execution risks.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is surging as a reported $53 billion takeover bid from Stripe and Advent International at $60.50 per share sparks intense speculation about the company's true intrinsic value. While the community is actively debating whether the bid is a bargain or an insult, investors are largely focused on the potential for a bidding war and the significant short interest that could fuel a massive squeeze if the board demands a higher price.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

AtaiBeckley is experiencing heightened investor attention driven by reports of potential acquisition interest from Eli Lilly, fueling speculation about a significant premium valuation. Community discussion is heavily focused on the potential for a bidding war, comparisons to broader sector movements, and ongoing debate regarding the company's long-term strategic direction versus short-term M&A opportunities.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as investors digest record monthly revenue data while positioning for the upcoming Q2 earnings report, which serves as a critical bellwether for the semiconductor sector's AI-driven demand. The community is intensely focused on forward guidance, CoWoS capacity expansion, and the broader implications for downstream partners like NVIDIA and AMD amid high market volatility.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is capturing significant attention as investors anticipate the upcoming durability data release for its psilocybin-based treatment, COMP360, which serves as a critical catalyst for its ongoing FDA rolling NDA submission. The community is actively discussing the stock's potential as a first-mover in the psychedelic sector, with many drawing comparisons to recent successes in the field and speculating on the likelihood of major pharmaceutical partnerships or acquisitions as regulatory pathways clarify.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently in the spotlight as investors position themselves ahead of the upcoming earnings report, with community discussion centered on whether the company will deliver an earnings beat to sustain its recent momentum. Shareholders are closely watching medical cost trends, institutional block trade activity, and potential guidance shifts, while debate continues over the stock's valuation and its role as a defensive anchor during broader market volatility.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently a major focus for traders as the stock tests long-term support levels near 52-week lows, with the community actively debating whether it presents a contrarian value opportunity or a long-term decline. Investors are polarized between those loading up on shares as a defensive hedge and bears pointing to waning foot traffic, menu pricing struggles, and the impact of the fast-food landscape as reasons for further downside.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to the company's recent strategic board appointments and leadership updates amid broader sector momentum fueled by an executive order to expedite research into psychedelic therapies. Community discussion is polarized, with some bulls highlighting the potential of the HLP003 breakthrough-designated program as a value play, while bears continue to raise concerns regarding cash burn, management turnover, and dilution risks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductor stocks are facing intense selling pressure and high volatility as investors scrutinize the sustainability of the AI capex boom and rotate capital into other market sectors. Market participants are actively debating whether this is a healthy consolidation phase for the sector or the beginning of a more significant correction driven by stretched valuations and concerns over chip demand.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is currently a focal point for investors as its U.S. listed ADR sees intense trading activity and extreme volatility following a highly anticipated public debut. The community is actively debating the sustainability of the stock's valuation premium compared to its primary South Korean listing, while simultaneously monitoring its critical role as a leading supplier of high-bandwidth memory for the booming AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Micro-Cap Biotech Stocks Surge After Breakthrough Psychedelics Licensing Announcement

The psychedelics market continues to expand rapidly as researchers gain a deeper understanding of its potential therapeutic benefits. Today, a leader in the sector announced a partnership with another micro-cap biotech company to further advance its development efforts in the space. Investors responded positively to the news, sending shares of both companies sharply higher following the announcement.PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) announced that it has signed a term sheet with Jupiter Neurosciences, Inc. (NASDAQ: JUNS) to grant the company exclusive perpetual U.S. ...

PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.

PharmAla Biotech Holdings Inc.

Neutral Sentiment

$100+

$80 - $99.99

$70 - $79.99

$60 - $69.99

Stripe and private equity firm Advent International just submitted a joint takeover offer for PayPal ($PYPL) at $60.50 per share, valuing the company at more than $53 billion - a roughly 28% premium to Tuesday's close. What do you think PayPal is really worth? Cast your vote and explain your reasoning in the comments.

What should PayPal ($PYPL) be worth in a takeover deal?

Feed

News

Sentiment

Fundamentals

Info

MDXXFPharmAla Biotech Holdings Inc.

Fundamentals

Latest MDXXF News